This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.

Completion of the following six (6) eLearning Presentations is necessary to qualify for accreditation:

    • District/National Perspectives on Harm Reduction
    • Interconnected Realities of Race, Gender, Class, and Harm Reduction in Substance Wellness
    • Panel Discussion - Harm Reduction and the Trans Experience
    • ADAP and Harm Reduction in Concert for Health Equity
    • Clinical Safety Nets: Prevention, Treatment, & Care Linkage in Harm Reduction
    • Streetwise Narratives and Narcan Training Workshop

Release Date: May 6, 2024
Expiration Date: May 6, 2025

UAN: JA4008162-9999-24-119-H01-P

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of clients with OUD/StUd and/or HIV.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe local and national harm reduction strategies.
  • Identify inclusive strategies to effectively address diverse and intersectional needs within harm reduction initiatives.
  • Promote comprehensive healthcare approaches for harm reduction to transform interventions aimed at reducing stigma.

Faculty
  • Kenan Zamore, Senior Research Epidemiologist, DC Health
  • Dr. Andrea M. Lopez, Associate Professor Dept of Anthropology, Univ. of Maryland
  • Tyree Williams, Co-Executive Director, Brothers Obtaining and Navigating Dynamic
  • Solidarity (BONDS)
  • Kaniya Walker, Lead Linkage To Care Navigator at Heart To Hand, Inc.
  • Taylor L Chandler, CEO TLC Consulting
  • Dane Ray LGPC, CEO D & A Consulting Services
  • Misty Carney, B.S., PharmD., AAHIVP Center Chief, Maryland Dept of Health
  • Erin Russell, MPH, Principal, Health Management Associates
  • George Kerr III, Founder and CEO of G III Associates
  • Anthony Green, Executive Director Caged Bird Productions
  • Abdur-Rahim Briggs, CEO Project Briggs
  • Dr. Ami Angell, Director of Outreach, The h3 Project
  • Kevin Fields PhD, Executive Director Father Factor
  • Kenya Hutton, President Capital Ballroom Council
  • Dr. O. Jermaine Bego, Senior Pastor CenterPoint Baptist Church
  • Sierra Barnedo, Street Outreach Manager, SMYAL
  • Tobie Smith, MD, MPH, Executive Director Street Health DC

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

The faculty presenter has nothing to disclose.

The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

Joint Accreditation Statement

Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 4 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 4 contact hour(s) (0. 4 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Physician Assistant Education

AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


Continuing Social Work Education

ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 4 Clinical continuing education credits.

Continuing Psychologist Education

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

Credit Designation: This program offers 4 continuing education credits for psychologists.

Interprofessional Continuing Education

IPCE Interprofessional Continuing Education logoThis activity was planned by and for the healthcare team, and learners will receive 4 Interprofessional Continuing Education (IPCE) credit for learning and change.



Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.